Cumberland Pharmaceuticals Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Cumberland Pharmaceuticals Inc. (CPIX) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$4.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$4.27M.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$3.29M, a 363.35% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.43M.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.95M.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$2.86M.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$6.44M.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$6.33M.
- Cumberland Pharmaceuticals Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$5.65M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$4.27M 10-Q · filed 2026-08-07 | -$7.56M 10-Q · filed 2026-08-07 | -$8.99M derived: sum of 3 quarters · filed 2026-08-07 | -$10.94M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$3.29M 10-Q · filed 2026-08-07 | -$4.72M derived: sum of 2 quarters · filed 2026-08-07 | -$6.66M derived: sum of 3 quarters · filed 2026-08-07 | -$7.40M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$1.43M 10-K · filed 2026-03-09 | -$3.38M derived: sum of 2 quarters · filed 2026-03-09 | -$4.11M derived: sum of 3 quarters · filed 2026-08-07 | -$2.86M 10-K · filed 2026-03-09 | |
| 2025-09-30 | -$1.95M 10-K · filed 2026-03-09 | -$2.68M derived: sum of 2 quarters · filed 2026-08-07 | -$1.44M 10-Q · filed 2025-11-07 | -$3.34M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$735.21K 10-Q · filed 2026-08-07 | $512.98K 10-Q · filed 2026-08-07 | -$1.39M derived: sum of 3 quarters · filed 2026-08-07 | -$2.93M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $1.25M 10-Q · filed 2026-08-07 | -$653.45K derived: sum of 2 quarters · filed 2026-08-07 | -$2.19M derived: sum of 3 quarters · filed 2026-08-07 | -$3.29M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2024-12-31 | -$1.90M 10-K · filed 2026-03-09 | -$3.44M derived: sum of 2 quarters · filed 2026-03-09 | -$4.54M derived: sum of 3 quarters · filed 2026-03-09 | -$6.44M 10-K · filed 2026-03-09 | |
| 2024-09-30 | -$1.54M 10-K · filed 2026-03-09 | -$2.64M derived: sum of 2 quarters · filed 2026-03-09 | -$4.54M 10-Q · filed 2025-11-07 | -$10.84M derived: sum of 4 quarters · filed 2026-03-09 | |
| 2024-06-30 | -$1.10M 10-K · filed 2026-03-09 | -$3.01M 10-Q · filed 2025-08-08 | -$9.31M derived: sum of 3 quarters · filed 2026-03-09 | -$10.37M derived: sum of 4 quarters · filed 2026-03-09 | |
| 2024-03-31 | -$1.90M 10-K · filed 2026-03-09 | -$8.20M derived: sum of 2 quarters · filed 2026-03-09 | -$9.27M derived: sum of 3 quarters · filed 2026-03-09 | -$8.41M derived: sum of 4 quarters · filed 2026-03-09 | |
| 2023-12-31 | -$6.30M 10-K · filed 2025-03-07 | -$7.37M derived: sum of 2 quarters · filed 2025-03-07 | -$6.50M derived: sum of 3 quarters · filed 2025-03-07 | -$6.33M 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$1.06M 10-K · filed 2025-03-07 | -$201.06K derived: sum of 2 quarters · filed 2025-03-07 | -$28.78K 10-Q · filed 2024-11-08 | -$2.49M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-06-30 | $862.15K 10-K · filed 2025-03-07 | $1.03M 10-Q · filed 2024-08-09 | -$1.43M derived: sum of 3 quarters · filed 2025-03-07 | -$1.85M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-03-31 | $172.29K 10-K · filed 2025-03-07 | -$2.29M derived: sum of 2 quarters · filed 2025-03-07 | -$2.71M derived: sum of 3 quarters · filed 2025-03-07 | -$4.08M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2022-12-31 | -$2.46M 10-K · filed 2024-03-13 | -$2.88M derived: sum of 2 quarters · filed 2024-03-13 | -$4.25M derived: sum of 3 quarters · filed 2024-03-13 | -$5.65M 10-K · filed 2024-03-13 | |
| 2022-09-30 | -$423.23K 10-K · filed 2024-03-13 | -$1.79M derived: sum of 2 quarters · filed 2024-03-13 | -$3.19M 10-Q · filed 2023-11-13 | -$7.07M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-06-30 | -$1.36M 10-K · filed 2024-03-13 | -$2.77M 10-Q · filed 2023-08-11 | -$6.65M derived: sum of 3 quarters · filed 2024-03-13 | -$7.74M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-03-31 | -$1.40M 10-K · filed 2024-03-13 | -$5.29M derived: sum of 2 quarters · filed 2024-03-13 | -$6.37M derived: sum of 3 quarters · filed 2024-03-13 | -$5.15M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2021-12-31 | -$3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$4.97M derived: sum of 2 quarters · filed 2023-03-13 | -$3.75M derived: sum of 3 quarters · filed 2023-03-13 | -$3.60M 10-K · filed 2023-03-13 | |
| 2021-09-30 | -$1.09M 10-Q · filed 2022-11-14 | $136.80K derived: sum of 2 quarters · filed 2022-11-14 | $281.46K 10-Q · filed 2022-11-14 | -$634.01K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $1.22M 10-Q · filed 2022-11-14 | $1.37M 10-Q · filed 2022-08-12 | $452.69K derived: sum of 3 quarters · filed 2022-11-14 | -$45.02K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-03-31 | $144.66K 10-Q · filed 2022-11-14 | -$770.80K derived: sum of 2 quarters · filed 2022-11-14 | -$1.27M derived: sum of 3 quarters · filed 2022-11-14 | -$2.21M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2020-12-31 | -$915.47K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$1.41M derived: sum of 2 quarters · filed 2022-03-11 | -$2.35M derived: sum of 3 quarters · filed 2022-03-11 | -$3.42M 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$497.70K 10-Q · filed 2021-11-12 | -$1.44M derived: sum of 2 quarters · filed 2021-11-12 | -$2.50M 10-Q · filed 2021-11-12 | -$2.50M 10-Q · filed 2020-11-13 | -$3.48M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | -$940.59K 10-Q · filed 2021-11-12 | -$2.01M 10-Q · filed 2021-08-13 | -$2.98M derived: sum of 3 quarters · filed 2022-03-11 | -$4.95M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-03-31 | -$1.07M 10-Q · filed 2021-11-12 | -$2.04M derived: sum of 2 quarters · filed 2022-03-11 | -$4.00M derived: sum of 3 quarters · filed 2022-03-11 | -$4.57M derived: sum of 4 quarters · filed 2022-03-11 | |
| 2019-12-31 | -$972.35K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$2.94M derived: sum of 2 quarters · filed 2022-03-11 | -$3.51M derived: sum of 3 quarters · filed 2022-03-11 | -$3.55M 10-K · filed 2022-03-11 | |
| 2019-09-30 | -$1.97M 10-Q · filed 2020-11-13 | -$2.53M derived: sum of 2 quarters · filed 2020-11-13 | -$2.57M 10-Q · filed 2020-11-13 | -$4.81M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-06-30 | -$566.81K 10-Q · filed 2020-11-13 | -$607.23K 10-Q · filed 2020-08-14 | -$2.84M derived: sum of 3 quarters · filed 2021-03-12 | -$4.51M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-03-31 | -$40.42K 10-Q · filed 2020-11-13 | -$2.28M derived: sum of 2 quarters · filed 2021-03-12 | -$3.94M derived: sum of 3 quarters · filed 2021-03-12 | -$4.69M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2018-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$3.90M derived: sum of 2 quarters · filed 2021-03-12 | -$4.65M derived: sum of 3 quarters · filed 2021-03-12 | -$7.04M 10-K · filed 2021-03-12 | |
| 2018-09-30 | -$1.66M 10-Q · filed 2019-11-13 | -$2.41M derived: sum of 2 quarters · filed 2019-11-13 | -$4.80M 10-Q · filed 2019-11-13 | -$5.62M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-06-30 | -$745.45K 10-Q · filed 2019-11-13 | -$3.14M 10-Q · filed 2019-08-14 | -$3.96M derived: sum of 3 quarters · filed 2020-12-10 | -$4.72M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-03-31 | -$2.39M 10-Q · filed 2019-11-13 | -$3.21M derived: sum of 2 quarters · filed 2020-12-10 | -$3.97M derived: sum of 3 quarters · filed 2020-12-10 | -$9.15M derived: sum of 4 quarters · filed 2020-12-10 | |
| 2017-12-31 | -$821.80K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$1.58M derived: sum of 2 quarters · filed 2020-12-10 | -$6.76M derived: sum of 3 quarters · filed 2020-12-10 | -$8.05M 8-K · filed 2020-12-10 | |
| 2017-09-30 | -$757.24K 10-Q · filed 2018-11-14 | -$5.93M derived: sum of 2 quarters · filed 2018-11-14 | -$7.23M 10-Q · filed 2018-11-14 | -$8.00M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-06-30 | -$5.18M 10-Q · filed 2018-08-14 | -$6.47M 10-Q · filed 2018-08-14 | -$7.24M derived: sum of 3 quarters · filed 2019-03-12 | -$7.15M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-03-31 | -$1.29M 10-Q · filed 2018-05-09 | -$2.06M derived: sum of 2 quarters · filed 2019-03-12 | -$1.97M derived: sum of 3 quarters · filed 2019-03-12 | -$2.03M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2016-12-31 | -$769.93K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$674.44K derived: sum of 2 quarters · filed 2019-03-12 | -$735.38K derived: sum of 3 quarters · filed 2019-03-12 | -$1.00M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $95.49K 10-Q · filed 2017-11-08 | $34.55K derived: sum of 2 quarters · filed 2017-11-08 | -$234.01K 10-Q · filed 2017-11-08 | -$105.41K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | -$60.94K 10-Q · filed 2017-08-09 | -$329.50K 10-Q · filed 2017-08-09 | -$200.90K derived: sum of 3 quarters · filed 2018-03-09 | -$79.20K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | -$268.56K 10-Q · filed 2017-05-15 | -$139.96K derived: sum of 2 quarters · filed 2018-03-09 | -$18.26K derived: sum of 3 quarters · filed 2018-03-09 | $376.04K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | $128.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $250.30K derived: sum of 2 quarters · filed 2018-03-09 | $644.60K derived: sum of 3 quarters · filed 2018-03-09 | $671.11K 10-K · filed 2018-03-09 | |
| 2015-09-30 | $121.70K 10-Q · filed 2016-11-03 | $516.00K derived: sum of 2 quarters · filed 2016-11-03 | $542.51K 10-Q · filed 2016-11-03 | $1.19M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | $394.30K 10-Q · filed 2016-08-05 | $420.81K 10-Q · filed 2016-08-05 | $1.07M derived: sum of 3 quarters · filed 2017-03-13 | $1.80M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | $26.51K 10-Q · filed 2016-05-13 | $675.08K derived: sum of 2 quarters · filed 2017-03-13 | $1.40M derived: sum of 3 quarters · filed 2017-03-13 | $2.11M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2014-12-31 | $648.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.38M derived: sum of 2 quarters · filed 2017-03-13 | $2.09M derived: sum of 3 quarters · filed 2017-03-13 | $2.36M 10-K · filed 2017-03-13 | |
| 2014-09-30 | $729.18K 10-Q · filed 2015-11-06 | $1.44M derived: sum of 2 quarters · filed 2015-11-06 | $1.71M 10-Q · filed 2015-11-06 | $202.51K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | $709.54K 10-Q · filed 2015-08-07 | $984.72K 10-Q · filed 2015-08-07 | -$526.68K derived: sum of 3 quarters · filed 2016-03-14 | -$1.36M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $275.18K 10-Q · filed 2015-05-15 | -$1.24M derived: sum of 2 quarters · filed 2016-03-14 | -$2.07M derived: sum of 3 quarters · filed 2016-03-14 | -$2.72M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$2.34M derived: sum of 2 quarters · filed 2016-03-14 | -$2.99M derived: sum of 3 quarters · filed 2016-03-14 | -$2.15M 10-K · filed 2016-03-14 | |
| 2013-09-30 | -$832.50K 10-Q · filed 2014-11-07 | -$1.48M derived: sum of 2 quarters · filed 2014-11-07 | -$640.02K 10-Q · filed 2014-11-07 | $1.15M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-06-30 | -$648.85K 10-Q · filed 2014-08-08 | $192.47K 10-Q · filed 2014-08-08 | $1.99M derived: sum of 3 quarters · filed 2015-03-09 | $3.85M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-03-31 | $841.33K 10-Q · filed 2014-05-12 | $2.64M derived: sum of 2 quarters · filed 2015-03-09 | $4.50M derived: sum of 3 quarters · filed 2015-03-09 | $6.23M derived: sum of 4 quarters · filed 2015-03-09 | |
| 2012-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $3.66M derived: sum of 2 quarters · filed 2015-03-09 | $5.39M derived: sum of 3 quarters · filed 2015-03-09 | $5.81M 10-K · filed 2015-03-09 | |
| 2012-09-30 | $1.86M 10-Q · filed 2013-11-06 | $3.60M derived: sum of 2 quarters · filed 2013-11-06 | $4.01M 10-Q · filed 2013-11-06 | $4.92M derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-06-30 | $1.74M 10-Q · filed 2013-08-09 | $2.15M 10-Q · filed 2013-08-09 | $3.06M derived: sum of 3 quarters · filed 2014-03-11 | $4.90M derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-03-31 | $413.84K 10-Q · filed 2013-05-08 | $1.32M derived: sum of 2 quarters · filed 2014-03-11 | $3.16M derived: sum of 3 quarters · filed 2014-03-11 | $5.33M derived: sum of 4 quarters · filed 2014-03-11 | |
| 2011-12-31 | $908.13K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $2.75M derived: sum of 2 quarters · filed 2014-03-11 | $4.92M derived: sum of 3 quarters · filed 2014-03-11 | $5.63M 10-K · filed 2014-03-11 | |
| 2011-09-30 | $1.84M 10-Q · filed 2012-11-02 | $4.01M derived: sum of 2 quarters · filed 2012-11-02 | $4.72M 10-Q · filed 2012-11-02 | $5.55M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-06-30 | $2.17M 10-Q · filed 2012-08-09 | $2.88M 10-Q · filed 2012-08-09 | $3.71M derived: sum of 3 quarters · filed 2013-03-12 | $4.71M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-03-31 | $711.28K 10-Q · filed 2012-05-04 | $1.54M derived: sum of 2 quarters · filed 2013-03-12 | $2.55M derived: sum of 3 quarters · filed 2013-03-12 | $2.82M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2010-12-31 | $832.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.83M derived: sum of 2 quarters · filed 2013-03-12 | $2.11M derived: sum of 3 quarters · filed 2013-03-12 | $2.43M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $1.00M 10-Q · filed 2011-11-07 | $1.28M derived: sum of 2 quarters · filed 2011-11-07 | $1.59M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $279.78K 10-Q · filed 2011-08-08 | $593.27K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $3.06M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |